Remedent, Inc. Receives Initial Purchase Order From CVS Pharmacy Stores

  
    
  
  
    
      Remedent, Inc. (OTCBB: REMI), an international company 
      specializing in the research, development, manufacturing of oral care 
      and cosmetic dentistry products, announced today that it has received a 
      significant initial purchase order for its iWhite teeth whitening system 
      from CVS Caremark Corporation. Under the terms of the order, Remedent 
      will initially ship this quarter two SKUs per store, one the iWhite 
      Light Activated Teeth Whitening Kit and the other the iWhite Maintenance 
      Stick. In addition to shipping these products to more than 6,200 CVS 
      drug stores for availability on the store shelves in April 2008, 
      Remedent will also deliver each SKU to various CVS warehouses across the 
      U.S.
    
    
      “We are very pleased to announce this initial 
      purchase order for our proprietary whitening solution, iWhite, with CVS 
      retail stores,” stated Mr. Robin List, Chief 
      Executive Officer of Remedent. “This purchase 
      order is a major breakthrough for Remedent in building the Company’s 
      presence in the U.S. market. CVS is one of the largest drug store chains 
      in the U.S. and a market leader within the retail industry. To support 
      this initiative, we plan on commencing a cooperative advertising and 
      media campaign with CVS and are hopeful to advancing iWhite into other 
      retail channels in the future.”
    
    
      About Remedent, Inc.
    
    
      Remedent, Inc., a publicly-traded company on the OTCBB, 
      specializes in the research, development, manufacturing and marketing of 
      oral care and cosmetic dentistry products. With offices in California, 
      Belgium and Singapore, Remedent distributes its products in more then 35 
      countries. For additional information, visit Remedent's web site at www.remedent.com.
    
    
      About CVS Caremark Corporation
    
    
      CVS Caremark is the nation's premier integrated pharmacy services 
      provider, combining one of the nation's leading pharmaceutical services 
      companies with the country’s largest pharmacy 
      chain. The company fills or manages more than one billion prescriptions 
      per year, more than any other pharmacy services provider. CVS Caremark 
      drives value for pharmacy services customers by effectively managing 
      pharmaceutical costs and improving healthcare outcomes through its 6,200 
      CVS/pharmacy stores; its pharmacy benefit management, mail order and 
      specialty pharmacy division, Caremark Pharmacy Services; its 
      retail-based health clinic subsidiary, MinuteClinic; and its online 
      pharmacy, CVS.com.
    
    
      FORWARD-LOOKING STATEMENTS
    
    
      “Safe Harbor” 
      Statement under the Private Securities Litigation Reform Act of 1995: 
      The statements by Robin List, optimism related to the business, 
      expanding sales, the US and international markets and other statements 
      in this press release are forward-looking statements within the meaning 
      of the Securities Litigation Reform Act of 1995. Such statements 
      are based on current expectations, estimates and projections about the 
      Company’s business. Words such as 
      expects, anticipates, intends, plans, believes, sees, estimates and 
      variations of such words and similar expressions are intended to 
      identify such forward-looking statements. These statements are not 
      guarantees of future performance and involve certain risks and 
      uncertainties that are difficult to predict. Actual results could 
      vary materially from the description contained herein due to many 
      factors including continued market acceptance of the Company’s 
      products. In addition, actual results could vary materially based 
      on changes or slower growth in the oral care and cosmetic dentistry 
      products market; the potential inability to realize expected benefits 
      and synergies; domestic and international business and economic 
      conditions; changes in the dental industry; unexpected difficulties in 
      penetrating the oral care and cosmetic dentistry products market; 
      changes in customer demand or ordering patterns; changes in the 
      competitive environment including pricing pressures or technological 
      changes; technological advances; shortages of manufacturing capacity; 
      future production variables impacting excess inventory and other risk 
      factors listed from time to time in the Company’s 
      Securities and Exchange Commission filings under “risk 
      factors” and elsewhere. The 
      forward-looking statements contained in this press release speak only as 
      of the date on which they are made, and the Company does not undertake 
      any obligation to update any forward-looking statement to reflect events 
      or circumstances after the date of this press release.